drugset / Trial / NCT00870142
A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
The purpose of this study to assess the single-dose relative bioavailability of Actavis Group hf and Pfizer (Norvasc®) 10 mg amlodipine besylate tablets, under fasting conditions.
Timeline
- Start
- 2005-04
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
Indications
No indication recorded.